335 related articles for article (PubMed ID: 20444900)
1. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses.
Lim ES; Malik HS; Emerman M
J Virol; 2010 Jul; 84(14):7124-34. PubMed ID: 20444900
[TBL] [Abstract][Full Text] [Related]
2. Counteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu gene.
Nikovics K; Dazza MC; Ekwalanga M; Mammano F; Clavel F; Saragosti S
PLoS One; 2012; 7(4):e35411. PubMed ID: 22530020
[TBL] [Abstract][Full Text] [Related]
3. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT
PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700
[TBL] [Abstract][Full Text] [Related]
4. Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs.
Yao W; Yoshida T; Hashimoto S; Takeuchi H; Strebel K; Yamaoka S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666374
[TBL] [Abstract][Full Text] [Related]
5. Anti-tetherin activities in Vpu-expressing primate lentiviruses.
Yang SJ; Lopez LA; Hauser H; Exline CM; Haworth KG; Cannon PM
Retrovirology; 2010 Feb; 7():13. PubMed ID: 20167081
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
Sauter D; Hué S; Petit SJ; Plantier JC; Towers GJ; Kirchhoff F; Gupta RK
Retrovirology; 2011 Dec; 8():103. PubMed ID: 22171785
[TBL] [Abstract][Full Text] [Related]
7. BST-2 mediated restriction of simian-human immunodeficiency virus.
Ruiz A; Lau D; Mitchell RS; Hill MS; Schmitt K; Guatelli JC; Stephens EB
Virology; 2010 Oct; 406(2):312-21. PubMed ID: 20708210
[TBL] [Abstract][Full Text] [Related]
8. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
Yoshida T; Koyanagi Y; Strebel K
J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
[TBL] [Abstract][Full Text] [Related]
9. Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.
Mack K; Starz K; Sauter D; Langer S; Bibollet-Ruche F; Learn GH; Stürzel CM; Leoz M; Plantier JC; Geyer M; Hahn BH; Kirchhoff F
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077643
[TBL] [Abstract][Full Text] [Related]
10. Lack of adaptation to human tetherin in HIV-1 group O and P.
Yang SJ; Lopez LA; Exline CM; Haworth KG; Cannon PM
Retrovirology; 2011 Sep; 8():78. PubMed ID: 21955466
[TBL] [Abstract][Full Text] [Related]
11. BST-2/tetherin: a new component of the innate immune response to enveloped viruses.
Evans DT; Serra-Moreno R; Singh RK; Guatelli JC
Trends Microbiol; 2010 Sep; 18(9):388-96. PubMed ID: 20688520
[TBL] [Abstract][Full Text] [Related]
12. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.
Gupta RK; Hué S; Schaller T; Verschoor E; Pillay D; Towers GJ
PLoS Pathog; 2009 May; 5(5):e1000443. PubMed ID: 19461879
[TBL] [Abstract][Full Text] [Related]
13. Tetherin: holding on and letting go.
Sauter D; Specht A; Kirchhoff F
Cell; 2010 Apr; 141(3):392-8. PubMed ID: 20434978
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of human and simian immunodeficiency viruses for resistance to tetherin/BST-2.
Serra-Moreno R; Evans DT
Curr HIV Res; 2012 Jun; 10(4):277-82. PubMed ID: 22524175
[TBL] [Abstract][Full Text] [Related]
15. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.
Sauter D; Schindler M; Specht A; Landford WN; Münch J; Kim KA; Votteler J; Schubert U; Bibollet-Ruche F; Keele BF; Takehisa J; Ogando Y; Ochsenbauer C; Kappes JC; Ayouba A; Peeters M; Learn GH; Shaw G; Sharp PM; Bieniasz P; Hahn BH; Hatziioannou T; Kirchhoff F
Cell Host Microbe; 2009 Nov; 6(5):409-21. PubMed ID: 19917496
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses.
Weinelt J; Neil SJ
J Virol; 2014 May; 88(10):5845-58. PubMed ID: 24623426
[TBL] [Abstract][Full Text] [Related]
17. Tetherin antagonism by primate lentiviral nef proteins.
Sauter D; Kirchhoff F
Curr HIV Res; 2011 Oct; 9(7):514-23. PubMed ID: 22103835
[TBL] [Abstract][Full Text] [Related]
18. The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function.
Kluge SF; Sauter D; Vogl M; Peeters M; Li Y; Bibollet-Ruche F; Hahn BH; Kirchhoff F
Retrovirology; 2013 Mar; 10():32. PubMed ID: 23514615
[TBL] [Abstract][Full Text] [Related]
19. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.
Rong L; Zhang J; Lu J; Pan Q; Lorgeoux RP; Aloysius C; Guo F; Liu SL; Wainberg MA; Liang C
J Virol; 2009 Aug; 83(15):7536-46. PubMed ID: 19474106
[TBL] [Abstract][Full Text] [Related]
20. Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.
Serra-Moreno R; Zimmermann K; Stern LJ; Evans DT
PLoS Pathog; 2013; 9(7):e1003487. PubMed ID: 23853598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
